After GLP-1: Understanding the Transition

In this episode

What actually happens to your body when a GLP-1 medication stops?

For many people, the answer isn't simply, "My appetite comes back."

There is a biological transition happening.

In Episode 1 of the After GLP-1 series, Sharon, Nurse Practitioner and host of the Stable Health Podcast, explores the biological and statistical realities of discontinuing GLP-1 therapy—and why maintaining weight loss afterward can be difficult without a structured plan.

This episode introduces the concept of the hormonal rebound: the return of biological signals that influence hunger, appetite, satiety, and energy balance once medication support is removed.

Sharon also examines what clinical studies have shown about weight regain following GLP-1 discontinuation and why regain should not automatically be interpreted as a lack of discipline or a failure of treatment.

Instead, the conversation introduces a different approach: the metabolic handoff.

Rather than thinking of the last injection as the end of treatment, the metabolic handoff treats it as a transition—one that requires intentional strategies to support appetite regulation, lean mass, nutrition, physical activity, and long-term metabolic health.

Because stopping the medication doesn't mean the biology that contributed to weight gain disappeared.

And maintaining progress requires more than willpower.

It requires a plan for what comes next.

The medication may stop. The strategy shouldn't.

Stay stable.

Support the show

All content is synthesized from peer-reviewed clinical evidence and reviewed by Stable Health Care Services. It does not constitute personalized medical advice.